Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

sanofi-aventis
1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 03/11/2009
PIL Fasturtec

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/11/2009 and displayed until Current
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 23/02/2009 and displayed until 03/11/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 26/04/2007 and displayed until 23/02/2009
Reasons for adding or updating:
  • Change to dosage and administration
  • PIL Retired pending re-submission
Updated on 26/04/2007 and displayed until 26/04/2007
Reasons for adding or updating:
  • Change to date of revision
  • Change to how to administer the medicine
  • Change to dosage and administration
  • PIL Retired pending re-submission
Updated on 17/07/2006 and displayed until 26/04/2007
Reasons for adding or updating:
  • Change of contra-indications
  • Change to side-effects
Updated on 21/10/2004 and displayed until 17/07/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
  rasburicase